A recombinant chimeric protein composed of human and mice-specific CD4+and CD8+T-cell epitopes protects against visceral leishmaniasis

Cross-protective efficacy of Leishmania infantum LiHyD protein against t egumentary leishmaniasis caused by Leishmania major and Leishmania braziliensis species

(2016) Daniela Pagliara Lage et al.   ACTA TROPICA

A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection

(2016) Mariana C. Duarte et al.   MOLECULAR IMMUNOLOGY

Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis

(2016) Malcolm S. Duthie et al.   VACCINE

Leishmania vaccine development: exploiting the host–vector–parasite interface

(2015) SG Reed et al.   Expert Review of Vaccines

Prophylactic properties of aLeishmania-specific hypothetical protein in a murine model of visceral leishmaniasis

(2015) D. P. Lage et al.   PARASITE IMMUNOLOGY

A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis

(2015) Vivian T. Martins et al.   Parasites & Vectors

Correction: Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis

(2015) Vivian Tamietti Martins et al.   PLoS One

New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment

(2015) Miguel Angel Chávez-Fumagalli et al.   Revista da Sociedade Brasileira de Medicina Tropical

Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis

(2015) Rajendra K Baharia et al.   PLoS Neglected Tropical Diseases

Immunogenicity Evaluation of a Rationally Designed Polytope Construct Encoding HLA-A*0201 Restricted Epitopes Derived from Leishmania major Related Proteins in HLA-A2/DR1 Transgenic Mice: Steps toward Polytope Vaccine

(2014) Negar Seyed et al.   PLoS One

Mimotope-Based Vaccines of Leishmania infantum Antigens and Their Protective Efficacy against Visceral Leishmaniasis

(2014) Lourena Emanuele Costa et al.   PLoS One

Modular Multiantigen T Cell Epitope-Enriched DNA Vaccine Against Human Leishmaniasis

(2014) S. Das et al.   Science Translational Medicine

Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen

(2014) Farnaz Zahedifard et al.   PLoS Neglected Tropical Diseases

Sensitive and Specific Serodiagnosis of Leishmania infantum Infection in Dogs by Using Peptides Selected from Hypothetical Proteins Identified by an Immunoproteomic Approach

(2013) Miguel A. Chávez-Fumagalli et al.   Clinical and Vaccine Immunology

Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice

(2013) JYOTI JOSHI et al.   PARASITOLOGY

New vaccines for neglected parasitic diseases and dengue

(2013) Coreen M. Beaumier et al.   Translational Research

Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis

(2013) Laura Ramírez et al.   VACCINE

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis

(2013) Noushin Saljoughian et al.   PLoS Neglected Tropical Diseases

Antigenicity and Protective Efficacy of a Leishmania Amastigote-specific Protein, Member of the Super-oxygenase Family, against Visceral Leishmaniasis

(2013) Vivian T. Martins et al.   PLoS Neglected Tropical Diseases

Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives

(2012) Ana Paula Fernandes et al.   CURRENT OPINION IN MICROBIOLOGY

Phenotyping of circulating CD8+ T cell subsets in human cutaneous leishmaniasis

(2012) Ali Khamesipour et al.   MICROBES AND INFECTION

Different Infective Forms Trigger Distinct Immune Response in Experimental Chagas Disease

(2012) Paula Melo de Abreu Vieira et al.   PLoS One

Leishmaniasis Worldwide and Global Estimates of Its Incidence

(2012) Jorge Alvar et al.   PLoS One

Performance of LBSap Vaccine after Intradermal Challenge with L. infantum and Saliva of Lu. longipalpis: Immunogenicity and Parasitological Evaluation

(2012) Bruno Mendes Roatt et al.   PLoS One

Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis

(2012) Maria Agallou et al.   VACCINE

Identification of Proteins in Promastigote and Amastigote-like Leishmania Using an Immunoproteomic Approach

(2012) Vinicio T. S. Coelho et al.   PLoS Neglected Tropical Diseases

Post-kala-azar dermal leishmaniasis: recent developments

(2011) Sarman Singh et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Analysis ofLeishmania chagasiby 2-D Difference Gel Eletrophoresis (2-D DIGE) and Immunoproteomic: Identification of Novel Candidate Antigens for Diagnostic Tests and Vaccine

(2011) Míriam M. Costa et al.   JOURNAL OF PROTEOME RESEARCH

Tafenoquine, an Antiplasmodial 8-Aminoquinoline, Targets Leishmania Respiratory Complex III and Induces Apoptosis

(2010) L. Carvalho et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

NetCTLpan: pan-specific MHC class I pathway epitope predictions

(2010) Thomas Stranzl et al.   IMMUNOGENETICS

Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania chagasi and Leishmania amazonensis challenge

(2010) Miguel A. Chávez-Fumagalli et al.   MICROBES AND INFECTION

CD8+ T Cells as a Source of IFN-γ Production in Human Cutaneous Leishmaniasis

(2010) Mahmoud Nateghi Rostami et al.   PLoS Neglected Tropical Diseases

NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction

(2009) Morten Nielsen et al.   BMC BIOINFORMATICS

Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies

(2008) Ifeoma Okwor et al.   IMMUNOLOGIC RESEARCH

Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7

(2008) A. H. Bakker et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one

(2008) Gad Baneth et al.   TRENDS IN PARASITOLOGY

Vaccines for leishmaniasis in the fore coming 25 years

(2008) Clarisa B. Palatnik-de-Sousa   VACCINE